The 13F Positions Funds Are Legally Allowed to Hide
Confidential treatment requests let managers delay disclosing their best ideas for up to a year — and the positions they hide tend to be the ones that work.
Every quarterly 13F carries an implicit promise: this is what the fund owned. It mostly is. But there is a legal carve-out that lets a manager leave specific positions off the public filing entirely, sometimes for a year, and it is used precisely when the position is one the manager most wants to keep quiet.
The mechanism is the confidential treatment request. It is not obscure, it is not a loophole, and it is not new — but it is badly understood by most people reading 13F data, and it quietly undermines the assumption that a filing is a complete snapshot.
How it works
Under Section 13(f), an institutional manager with over $100 million in qualifying US equities must file within 45 days of quarter end. Alongside that filing, the manager can ask the SEC to withhold specific line items from public view. If the request is granted, those holdings simply do not appear. The rest of the portfolio publishes normally, and nothing on the face of the document announces that something is missing.
When the confidentiality period expires, the manager files an amended 13F — a 13F-HR/A — and the hidden positions appear, dated back to the original quarter end. That is the only moment the public learns they existed.
Blackstone is a clean 2026 illustration. Confidential treatment attached to its May 15 filing expired on August 14, and the amendment that followed disclosed four positions that had been invisible for a full quarter. Nothing improper happened. The process worked exactly as designed. But anyone who analyzed Blackstone's Q1 portfolio in May was working from an incomplete file and had no way to know it.
Why managers ask
The stated rationale is front-running. A fund building a large stake in a mid-cap over several quarters has a real problem if the market learns about it halfway through — copycat buying moves the price against the remaining accumulation. Activists face a sharper version: revealing a stake before the campaign starts hands leverage to the target company.
The SEC is openly skeptical of this argument. Staff guidance is blunt that many filers assume confidential treatment will be granted on a superficial showing of need, and that the Division grants it only in limited circumstances. The reasoning is hard to argue with: 13F data is already 45 days stale by the time it publishes. Something more than ordinary competitive discomfort is required.
Two patterns show up in the academic work on this. Confidential positions skew toward illiquid securities — consistent with genuine accumulation concerns rather than secrecy for its own sake. And they earn positive, statistically significant abnormal returns over the non-disclosure window. Managers are not hiding random holdings. They are hiding the ones that are working.
What this means for reading filings
Three practical consequences.
A 13F is a floor, not a complete portfolio. The positions you can see are real. The absence of a position is weaker evidence than it looks — the fund may hold it and simply not be showing it yet. When a manager you follow appears to have no exposure to a theme you would expect them to be in, that is a question rather than an answer. Position histories on the investor pages are worth reading with that caveat in mind.
Amendments deserve as much attention as originals. Almost all confidential filings surface more than a quarter after the reference date, long after the original filing has been analyzed, written up, and forgotten. By the time the amendment lands, the news cycle has moved on and almost nobody re-reads the quarter. That is exactly why the information is still there to find.
Concentration figures can be wrong in one direction. If a fund shows twenty holdings and three are withheld, the reported concentration, sector weights, and turnover are all computed off a partial base. This matters most for smaller books, where a single hidden position can be a meaningful share of the portfolio. Cross-fund comparisons on the overlap view are more reliable for large diversified managers than for concentrated ones, for this reason among others.
The honest framing
None of this makes 13F data useless. It makes it what it always was: a lagged, partial, backward-looking disclosure that is still the best public window into institutional positioning that exists. The error is not using it. The error is treating it as complete.
The funds most likely to use confidential treatment are the ones running concentrated, illiquid, high-conviction books — which is to say, the ones whose filings people most want to read. The gap is largest exactly where the interest is highest. Reading around it means checking amendments, treating absence as ambiguous, and holding conclusions about a manager's positioning loosely until a few quarters of filings agree with each other. The aggregate signals on the macro consensus view hold up better than single-fund snapshots for the same reason: what one manager hides, a hundred managers cannot.
Data sourced from public SEC 13F filings. Educational research only — not investment advice.
Explore the full data behind this analysis on InvestorLens.
View Investor Portfolios →